Giving uridine and/or docosahexaenoic acid orally to rat dams during gestation and nursing increases synaptic elements in brains of weanling pups

Developmental Neuroscience

Volumn 31, Issue 3, 2009, Pages 181-192

  Cansev, Mehmet ^a,b   Marzloff, George ^a   Sakamoto, Toshimasa ^a,c   Ulus, Ismail H ^a,b   Wurtman, Richard J ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ULUDAG UNIVERSITY   (Turkey)

^c KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

Dendritic spines; Development; Docosahexaenoic acid; Infant nutrition; Membrane phosphatides; Synaptic proteins; Synaptogenesis; Uridine

Indexed keywords

DOCOSAHEXAENOIC ACID; PHOSPHOLIPID; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSIN I; URIDINE PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIRTH; BRAIN; BRAIN DEVELOPMENT; BREAST FEEDING; CONTROLLED STUDY; DENDRITIC SPINE; DRUG EFFECT; DRUG MECHANISM; FEMALE; FETUS; HIPPOCAMPUS; LACTATION; MATERNAL NUTRITION; NEWBORN; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RAT; SUPPLEMENTATION; SYNAPSE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; DENDRITES; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FEMALE; PHOSPHOLIPIDS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SYNAPSES; URIDINE;

EID: 67649111166     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193394     Document Type: Article

References (86)

1. Abe K, Kogure K, Yamamoto H, Imazawa M, Miyamoto K (1987): Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J Neurochem 48: 503- 509.
2. Araki W, Wurtman RJ (1997): Control of membrane phosphatidylcholine synthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth. Proc Natl Acad Sci USA 94: 11946-11950.
3. Arthur DB, Akassoglou K, Insel PA (2005): P2Y2 receptor activates nerve growth factor/TrkA signaling to enhance neuronal differentiation. Proc Natl Acad Sci 102: 19138-19143.
4. Babb SM, Ke Y, Lange N, Kaufman MJ, Renshaw PF, Cohen BM (2004): Oral choline increases choline metabolites in human brain. Psychiatry Res 130: 1-9.
5. Baldwin SA, Beal PR, Yao SYM, King AE, Cass CE, Young JD (2004): The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447: 735-743.
6. Blusztajn JK (1998): Choline, a vital amine. Science 281: 794-795.
7. Bokor S, Koletzko B, Decsi T (2007): Systematic review of fatty acid composition of human milk from mothers of preterm compared to full-term infants. Ann Nutr Metab 51: 550- 556.
8. Breckenridge WC, Gombos G, Morgan IG (1972): The lipid composition of adult rat brain synaptosomal plasma membranes. Biochim Biophys Acta 266: 695-707.
9. Burnstock G (2007): Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483.
10. Canellakis ES (1957): Pyrimidine metabolism. II. Enzymatic pathways of uracil anabolism. J Biol Chem 227: 329- 338.
11. Cansev M, Watkins CJ, van der Beek EM, Wurtman RJ (2005): Oral uridine 5 - monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res 1058: 101-108.
12. Cansev M (2006): Uridine and cytidine in the brain: their transport and utilization. Brain Res Brain Res Rev 52: 389-397.
13. Cansev M (2007): Involvement of uridine-nucleotide- stimulated P2Y receptors in neuronal growth and function. Cent Nerv Syst Agents Med Chem 7: 223-229.
14. Cansev M, Wurtman RJ (2007): Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 148: 421- 431.
15. Cavaliere F, Nestola V, Amadio S, D'Ambrosi N, Angelini DF, Sancesario G, Bernardi G, Volonte C (2005): The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol Dis 18: 100-109.
16. Cho E, Zeisel SH, Jacques P, Selhub J, Dougherty L, Colditz GA, Willett WC (2006): Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr 83: 905-911.
17. Chorna NE, Santiago-Perez LI, Erb L, Seye CI, Neary JT, Sun GY, Weisman GA, Gonzalez FA (2004): P2Y2 receptors activate neuroprotective mechanisms in astrocytic cells. J Neurochem 91: 119-132.
18. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW (1980a): Extrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4: 121-129.
19. Clandinin MT, Chappell JE, Leong S, Heim T, Swyer PR, Chance GW (1980b): Intrauterine fatty acid accretion rates in human brain: implications for fatty acid requirements. Early Hum Dev 4: 131-138.
20. Cohen EL, Wurtman RJ (1976): Brain acetylcholine: control by dietary choline. Science 191: 561-562.
21. Cornell RB (1992): Cholinephosphotransferase from mammalian sources. Methods Enzymol 209: 267-272.
22. Cornford EM, Cornford ME (1986): Nutrient transport and the blood-brain barrier in developing animals. Fed Proc 45: 2065-2072.
23. Darios F, Davletov B (2006): Omega-3 and omega- 6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 440: 813-817.
24. DeGeorge JJ, Nariai T, Yamazaki S, Williams WM, Rapoport SI (1991): Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J Neurochem 56: 352-355.
25. Dunstan JA, Mitoulas LR, Dixon G, Doherty DA, Hartmann PE, Simmer K, Prescott SL (2007): The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res 62: 689-694.
26. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS (2000): PSD-95 involvement in maturation of excitatory synapses. Science 290: 1364-1368.
27. Ferreira A, Rapoport M (2002): The synapsins beyond the regulation of neurotransmitter release. Cell Mol Life Sci 59: 589-595.
28. Fujita A, Kurachi Y (2000): SAP family proteins. Biochem Biophys Res Commun 269: 1-6.
29. Garcia MC, Ward G, Ma YC, Salem N Jr, Kim HY (1998): Effect of docosahexaenoic acid on the synthesis of hosphatidylserine in rat brain microsomes and C6 glioma cells. J Neurochem 70: 24-30.
30. Garner SC, Mar M-H, Zeisel SH (1995): Choline distribution and metabolism in pregnant rats and fetuses are influenced by the choline content of the maternal diet. J Nutr 125: 2851-2858.
31. Gray JH, Owen RP, Giacomini KM (2004): The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447: 728-734.
32. Hayashi TT, Garvey BI (1968): Transplacental passage of nucleotides, nucleosides and bases. Am J Obstet Gynecol 102: 1154-1161.
33. Hering H, Sheng M (2001): Dendritic spines: structure, dynamics and regulation. Nat Rev Neurosci 2: 880-888.
34. Holmes-McNary MQ, Cheng WL, Mar MH, Fussell S, Zeisel SH (1996): Choline and choline esters in human and rat milk and in infant formulas. Am J Clin Nutr 64: 572-576.
35. Ilcol YO, Ozbek R, Hamurtekin E, Ulus IH (2005): Choline status in newborns, infants, children, breast-feeding women, breast-fed infants and human breast milk. J Nutr Biochem 16: 489-499.
36. Innis SM (2004): Polyunsaturated fatty acids in human milk: an essential role in infant development. Adv Exp Med Biol 554: 27-43.
37. Innis SM (2005): Essential fatty acid transfer and fetal development. Placenta 26:S70-S75.
38. Institute of Medicine, National Academy of Science USA (1998): Choline; in Dietary Reference Intakes for Folate, Thiamine, Riboflavin, Niacin, Vitamin B12, Panthothenic Acid, Biotin, and Choline. Washington, National Academy Press, pp 390-422.
39. Kennedy EM, Weiss SB (1956): The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 222: 193-214.
40. Kizaki H, Williams JC, Morris HP, Weber G (1980): Increased cytidine-5 - -triphosphate synthetase activity in rat and human tumors. Cancer Res 40: 3921-3927.
41. Klein J, Gonzalez R, Koppen A, Loffelholz K (1993): Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 22: 293- 300.
42. Koletzko B, Larque E, Demmelmair H (2007): Placental transfer of long-chain polyunsaturated fatty acids (LC- PUFA). J Perinat Med 35:S5-S11.
43. Kothapalli KSD, Anthony JC, Pan BS, Hsieh AT, Nathanielsz PW, Brenna JT (2007): Differential cerebral cortex transcriptomes of baboon neonates consuming moderate and high docosahexaenoic acid formulas. PLoS ONE 2:e370.
44. Labarca C, Paigen K (1980): A simple, rapid and sensitive DNA assay procedure. Anal Biochem 102: 344-352.
45. Larque E, Krauss-Etschmann S, Campoy C, Hartl D, Linde J, Klingler M, Demmelmair H, Cano A, Gil A, Bondy B, Koletzko B (2006): Docosahexaenoic acid supply in pregnancy affects placental expression of fatty acid transport proteins. Am J Clin Nutr 84: 853-861.
46. Lieberman I (1956): Enzymatic amination of uridine triphosphate to cytidine triphosphate. J Biol Chem 222: 765- 775.
47. Mages F, Rey C, Fonlupt P, Pacheco H (1988): Kinetic and biochemical properties of CTP: choline-phosphate cytidylyltransferase from the rat brain. Eur J Biochem 178: 367-372.
48. Mandel P, Edel-Harth S (1966): Free nucleotides in the rat brain during post-natal development. J Neurochem 13: 591-595.
49. Mantel CR, Schulz AR, Miyazawa K, Broxmeyer HE (1993): Kinetic selectivity of cholinephosphotransferase in mouse liver: the Km for CDP-choline depends on diacylglycerol structure. Biochem J 289: 815-820.
50. Marszalek JR, Lodish HF (2005): Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you. Annu Rev Cell Dev Biol 21: 633-657.
51. Martinez M (1992): Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr 120:S129-S138.
52. McCann JC, Ames BN (2005): Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in human and animals. Am J Clin Nutr 82: 281- 295.
53. Meck W, Smith AR, Williams C (1988): Pre- and postnatal choline supplementation produces long-term supplementation of spatial memory. Dev Psychobiol 21: 339-353.
54. Millington WR, Wurtman RJ (1982): Choline administration elevates brain phosphorylcholine concentrations. J Neurochem 38: 1748-1752.
55. Molloy AM, Mills JL, Cox C, Daly SF, Conley M, Brody LC, Kirke PN, Scott JM, Ueland PM (2005): Choline and homocysteine interrelations in umbilical cord and maternal plasma at delivery. Am J Clin Nutr 82: 836-842.
56. Nakanishi S, Nakajima Y, Masu M, Ueda Y, Nakahara K, Watanabe D, Yamaguchi S, Kawabata S, Okada M (1998): Glutamate receptors: brain function and signal transduction. Brain Res Brain Res Rev 26: 230-235.
57. Nimchinsky EA, Sabatini BL, Svoboda K (2002): Structure and function of dendritic spines. Annu Rev Physiol 64: 313-353.
58. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ (1992): Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci USA 89: 1671- 1675.
59. O'Brien JS, Sampson EL (1965): Fatty acid and fatty aldehyde composition of the major brain lipids in normal human gray matter, white matter, and myelin. J Lipid Res 6: 545- 551.
60. Orengo A (1969): Regulation of enzymic activity by metabolites. I. Uridine-cytidine kinase of Novikoff ascites rat tumor. J Biol Chem 244: 2204-2209.
61. Pooler AM, Guez DH, Benedictus R, Wurtman RJ (2005): Uridine enhances neurite outgrowth in nerve growth factor-differentiated pheochromocytoma cells. Neuroscience 134: 207-214.
62. Rice D, Barone S Jr (2000): Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(suppl 3):511-533.
63. Richardson UI, Watkins CJ, Pierre C, Ulus IH, Wurtman RJ (2003): Stimulation of CDPcholine synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Brain Res 971: 161-167.
64. Richardson UI, Wurtman RJ (2007): Polyunsaturated fatty acids stimulated phosphatidylcholine synthesis in PC12 cells. Biochim Biophys Acta 1771: 558-563.
65. Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ (1997): Phospholipid biosynthetic enzymes in human brain. Lipids 32: 351-358.
66. Sakamoto T, Cansev M, Wurtman RJ (2007): Oral supplementation with docosahexaenoic acid and uridine-5 - -monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 1182: 50-59.
67. Sarda N, Gharib A, Moliere P, Grange E, Bobillier P, Lagarde M (1991): Docosahexaenoic acid (cervonic acid) incorporation into different brain regions in the awake rat. Neurosci Lett 123: 57-60.
68. Sastry PS (1985): Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 24: 69-176.
69. Schwenk M, Hegazy E, Lopez del Pino V (1984): Uridine uptake by intestinal epithelial cells of guinea pig. Biochim Biophys Acta 805: 370-374.
70. Spanner S, Ansell GB (1979): Choline kinase and ethanolamine kinase activity in the cytosol of nerve endings from rat forebrain. Biochem J 178: 753-760.
71. Svennerholm L (1968): Distribution and fatty acid composition of phosphoglycerides in normal human brain. J Lipid Res 9: 570-579.
72. Tam O, Innis SM (2006): Dietary polyunsaturated fatty acids in gestation alter fetal cortical phospholipids, fatty acids and phosphatidylserine synthesis. Dev Neurosci 28: 222-229.
73. Teng FYH, Wang Y, Tang BL (2001): The syntaxins. Genome Biol 2:reviews3012.1-3012.7.
74. Thorell L, Sjoberg LB, Hernell O (1996): Nucleotides in human milk: sources and metabolism by the newborn infant. Pediatr Res 40: 845-852.
75. Tou JS (1986): Acylation of docosahexaenoic acid into phospholipids by intact human neutrophils. Lipids 21: 324- 327.
76. Ward GR, Huang YS, Bobik E, Xing HC, Mutsaers L, Auestad N, Montalto M, Wainwright P (1998): Long-chain polyunsaturated fatty acid levels in formulae influence deposition of docosahexaenoic acid and arachidonic acid in brain and red blood cells of artificially reared neonatal rats. J Nutr 128: 2473- 2487.
77. 3 H)choline in human term placenta fragments. Biochem Pharmacol 25: 1021-1030.
78. Wurtman RJ, Regan M, Ulus I, Yu L (2000): Effect of oral CDP-choline on plasma choline and uridine levels in humans. Biochem Pharmacol 60: 989-992.
79. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G (2006): Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 1088: 83-92.
80. Wurtman RJ, Cansev M, Ulus IH (in press): Choline and its products acetylcholine and phosphatidylcholine; in Tettamanti G, Gianfrancesco G, Lajtha A (eds): Neural Lipids: Handbook of Neurochemistry and Molecular Neurobiology. Berlin, Springer, vol 8, part 3.
81. Yu VYH (2002): Scientific rationale and benefits of nucleotide supplementation of infant formula. J Paediatr Child Health 38: 543-549.
82. Yuste R, Bonhoeffer T (2004): Genesis of dendritic spines: insights from ultrastructural and imaging studies. Nat Rev Neurosci 5: 24- 34.
83. Zeisel SH, Epstein MF, Wurtman RJ (1980): Elevated choline concentration in neonatal plasma. Life Sci 26: 1827- 831.
84. Zeisel SH, Blusztajn JK (1994): Choline and human nutrition. Annu Rev Nutr 14: 269-296.
85. Zeisel SH (2000): Choline: an essential nutrient for humans. Nutrition 16: 669-671.
86. Zeisel SH (2006): Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr 26: 229-250.